甲苯磺酸索拉非尼

中文名称： 甲苯磺酸索拉非尼 中文别名： 4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺对甲苯磺酸盐; 对甲苯磺酸索拉非尼; 对甲苯酸索尼替尼; 索拉非尼对甲苯磺酸盐; 甲苯磺酸索拉菲尼; 甲磺酸索拉菲尼 英文名称： Sorafenib tosylate 英文别名： SORAFENIB-D3; 4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea Tolsylate; Sorafenib TsOH salt CAS号： 475207-59-1;4750207-59-1 分子式： C21H16ClF3N4O3·C7H8SO 分子量： 637.03 分子结构： [甲苯磺酸索拉非尼 475207-59-1;4750207-59-1]

Beijing HOPE Pharmaceutical Co., Ltd. (stock number 836438), founded in 2005 and located in Beijing Economic and technological development Zone. It is a high-tech enterprise focused on research and development of chemical drug . Hope got self-support imp & exp rights, dedicated to R&D, manufacture, sales and technology transfer service of APIs, intermediates and preparations. Hope owns a high-level R&D team and has established a strict scientific research management system and a diversified service system. Through years of technical accumulation and steady development, Hope has been nam